Material that is described in commerce as "retatrutide" is therefore either (a) supplied to participants enrolled in an Eli Lilly clinical trial, (b) supplied as a chemical reference standard for laboratory research use only, or (c) sold illicitly, which has been the focus of FDA enforcement [5][6][13][14]
While MYOS is a proponent of evidence-based treatment of clinical obesity with obesity management medications (OMMs), we are deeply concerned about the safety, quality, and legality of these unregulated products
Great news
Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death
In your hospital room, youll meet one of the nurses who will care for you during your stay
GLP-1 medications, peptides, NAD, and even exosome therapies have moved from niche clinical research into popular discussion